NDC 0555-0572

Methotrexate

Methotrexate

Methotrexate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Methotrexate Sodium.

Product ID0555-0572_3d118f0f-cddd-4b6a-9784-527097734093
NDC0555-0572
Product TypeHuman Prescription Drug
Proprietary NameMethotrexate
Generic NameMethotrexate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1990-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA081099
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameMETHOTREXATE SODIUM
Active Ingredient Strength3 mg/1
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0555-0572-02

100 TABLET in 1 BOTTLE (0555-0572-02)
Marketing Start Date1990-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0555-0572-35 [00555057235]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1990-11-01

NDC 0555-0572-48 [00555057248]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1990-11-01
Marketing End Date2011-01-25

NDC 0555-0572-02 [00555057202]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1990-11-01

NDC 0555-0572-04 [00555057204]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1990-11-01
Marketing End Date2011-01-25

NDC 0555-0572-49 [00555057249]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1990-11-01
Marketing End Date2011-01-25

NDC 0555-0572-45 [00555057245]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1990-11-01
Marketing End Date2011-01-25

NDC 0555-0572-46 [00555057246]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1990-11-01
Marketing End Date2011-01-25

NDC 0555-0572-47 [00555057247]

Methotrexate TABLET
Marketing CategoryANDA
Application NumberANDA081099
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1990-11-01
Marketing End Date2011-01-25

Drug Details

Pharmacological Class

  • Folate Analog Metabolic Inhibitor [EPC]
  • Folic Acid Metabolism Inhibitors [MoA]

NDC Crossover Matching brand name "Methotrexate" or generic name "Methotrexate"

NDCBrand NameGeneric Name
0143-9367MethotrexateMethotrexate
0143-9516MethotrexateMethotrexate
0143-9517MethotrexateMethotrexate
0143-9518MethotrexateMethotrexate
0143-9519MethotrexateMethotrexate
0143-9830MethotrexateMethotrexate
0378-0014Methotrexatemethotrexate
0555-0572MethotrexateMethotrexate
0703-3671MethotrexateMethotrexate
0703-3675MethotrexateMethotrexate
0703-3678MethotrexateMethotrexate
68382-775MethotrexateMethotrexate
69238-1423MethotrexateMethotrexate
70518-0223METHOTREXATEMETHOTREXATE
70518-1251MethotrexateMethotrexate
70518-1398MethotrexateMethotrexate
70771-1058MethotrexateMethotrexate
71335-0782MethotrexateMethotrexate
16729-277MethotrexateMethotrexate
21695-111MethotrexateMethotrexate
42291-594MethotrexateMethotrexate
42254-110METHOTREXATEMETHOTREXATE
43063-439MethotrexateMethotrexate
47335-235MethotrexateMethotrexate
50090-0294METHOTREXATEMETHOTREXATE
50090-2345MethotrexateMethotrexate
50090-3418MethotrexateMethotrexate
51079-670MethotrexateMethotrexate
51407-121MethotrexateMethotrexate
61703-350MethotrexateMethotrexate
61703-408MethotrexateMethotrexate
63323-122MethotrexateMethotrexate
63323-123MethotrexateMethotrexate
66336-338METHOTREXATEMETHOTREXATE
67253-320METHOTREXATEMETHOTREXATE
67457-480MethotrexateMethotrexate
67457-466MethotrexateMethotrexate
71335-1118MethotrexateMethotrexate
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.